About: Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.00 (-0.91%)
LSTA NASDAQ Lisata Therapeutics Inc.
Lisata Therapeutics Inc. share price
Atividade de preço de LSTA
Último preço
$ 1,000
Variação (24h)
-0,01 USD (0,91%)
Volume
45.56K
Volume (média 4 sem.)
-
Abertura
$ 0,99
Variação do dia
$ 0,97 - $ 1,01
Fechamento anterior
$ 1,01
Último negócio
23 Oct, 8:00 pm GMT+0
Atrasado
23 Oct, 8:00 pm GMT+0
LSTA price performance
Atrasado
23 Oct, 8:00 pm GMT+0
quote.marketSignals